InvestorsHub Logo
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

Re: lorbas95 post# 26907

Tuesday, 07/02/2019 9:11:52 AM

Tuesday, July 02, 2019 9:11:52 AM

Post# of 34625

Possibly, but it is always problematic to use inflated buyout prices in past hype periods for future predictions. I don't think Gilead and especially Celgene would pay that much again today.



I know for a fact that these acquisitions, and the prices paid, were predicated on the hope that CAR-T would be effective in solid tumors, which hasn't really panned out, at least not yet.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News